Banhbao TV

MSD and VNVC announce planned cooperation on vaccine technology

MSD and Vietnam Vaccine Joint Stock Company (VNVC) have announced a plan covering technology transfer, manufacturing and localisation of strategic vaccine products in Vietnam.

MSD and VNVC representatives at the ceremony announcing a planned partnership in Vietnam
Vietnam News

MSD and Vietnam Vaccine Joint Stock Company (VNVC) have announced a plan covering technology transfer, manufacturing and localisation of strategic vaccine products.

The agreement was announced in the presence of Minister of Health Dao Hong Lan, Deputy Minister of Science and Technology Le Xuan Dinh, Deputy Minister of Foreign Affairs Dang Hoang Giang and representatives of relevant government agencies.

The announcement came during a visit to Vietnam by MSD’s senior leadership and laid the groundwork for further transfer to VNVC of scientific knowledge, technical expertise, quality processes and manufacturing capabilities. The ceremony was attended by Marc Gailhardou, president of MSD’s Intercontinental Region; Andrew Otoo, president of MSD in Asia Pacific; Ngô Chí Dũng, VNVC’s chairman and CEO; and other stakeholders.

“MSD looks forward to bringing more than 130 years of global expertise to this planned partnership. We are equally encouraged by VNVC’s local leadership, investment and long-term vision. By combining our respective strengths, we hope to support stronger disease prevention efforts and deliver lasting benefits for the health of the Vietnamese people,” said Marc Gailhardou, president of MSD’s Intercontinental Region.

Ngô Chí Dũng said VNVC has worked closely with MSD for many years, bringing millions of vaccine doses to people in Vietnam each year. Building on that cooperation, the two companies are working on a strategic plan covering technology transfer, manufacturing and localisation of strategic vaccine products. The plan is linked to Vietnam’s goal of advancing science and technology and strengthening healthcare self-reliance.

VNVC chairman and CEO Ngô Chí Dũng speaking at the ceremony

“VNVC views high-tech vaccine manufacturing as a long-term strategy that requires significant investment in technology, human resources and quality management. We have invested in the development of a modern manufacturing facility and are building the foundation to receive and progressively master advanced technologies. Our plan to collaborate with MSD marks an important step forward, opening opportunities to access world-leading vaccine manufacturing technologies, strengthen domestic supply capabilities, expand access to vaccines and enhance Vietnam’s position in the global vaccine industry,” Ngô Chí Dũng said.

Later that day, MSD leaders met with Deputy Prime Minister Phạm Thị Thanh Trà. The discussions focused on Vietnam’s healthcare priorities, the role of science, technology and innovation in healthcare, and opportunities to strengthen cooperation between the government and the private sector. MSD shared details of its plan with VNVC on technology transfer, manufacturing and localisation of strategic vaccine products. The parties also discussed ways to expand access to innovative medicines and quality vaccines and contribute to a more sustainable healthcare system.

The planned partnership between MSD and VNVC, together with the high-level meetings during the visit, shows the role of cooperation, science and innovation in the sustainable development of Vietnam’s healthcare system.

MSD leaders meeting Vietnam’s deputy prime minister

VNVC operates one of Vietnam’s leading vaccination networks, with nearly 300 centres nationwide offering a wide range of vaccines for children and adults. The company has more than 12,000 employees. VNVC has invested in GSP-standard cold storage facilities that comply with international requirements, advanced cold-chain systems and a qualified team of doctors and nurses to provide safe, high-quality vaccination services. Through strategic partnerships with leading global vaccine manufacturers, VNVC continues to expand access to advanced vaccines and contribute to a reliable vaccine supply in Vietnam.

MSD, known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada, has developed important medicines and vaccines for more than 130 years.

Sources: Viet Nam News